Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML. Blood advances El Chaer, F., Borate, U., Dulery, R., Holtan, S. G., Law, A. D., Muffly, L., Nassereddine, S., Shallis, R. M., Stringaris, K., Taylor, J., Devine, S. M., Mohty, M., Hourigan, C. S. 2021; 5 (6): 1757–59
View details for DOI 10.1182/bloodadvances.2020003839
View details for PubMedID 33755090